📍 AUROPHARMA broke above the 1H VRZ High at ₹1607.50, attracting traders looking for a Bearish Breakout Failure (BOF) after the initial breakout. 🟢
⚠️ However, the expected rejection never developed.
📈 Instead of falling back below the VRZ High, price continued holding above the breakout level, showing healthy buyer acceptance.
🐂 Buyers successfully defended the reclaimed resistance and maintained control throughout the session.
🚫 Sellers were unable to push the price back below the VRZ High, preventing BOF confirmation.
🎯 Result: A clear BOF Failure, where the breakout remained valid and buyers sustained strength above resistance.
💭 Did sellers reject the breakout?
They attempted to create selling pressure, but buyers quickly absorbed it.
💭 Was there a strong move back below ₹1607.50?
No. Price continued to hold above the VRZ High with sustained acceptance.
💭 Who controlled the market after the breakout?
🐂 Buyers remained firmly in control, protecting the breakout zone.
💭 What happened to traders expecting a BOF reversal?
Without bearish confirmation, short sellers were trapped as the breakout continued to remain valid.
➡️ Price successfully reclaimed and held above the 1H VRZ High.
➡️ No bearish follow-through developed after the breakout.
➡️ Buyers maintained strong acceptance above the resistance zone.
➡️ Sellers failed to force price back below the VRZ level.
➡️ Market structure continued to favor bullish continuation.
✅ A breakout alone doesn't guarantee a BOF opportunity.
✅ Holding above the breakout zone is a sign of buyer strength.
✅ Failed bearish confirmation usually indicates continuation rather than reversal.
✅ Always trade confirmed BOF setups—not anticipated reversals.
